Pricing Log in Create free account

IGC Pharma, Inc. (IGC) vs NextCure, Inc. (NXTC)

IGC Pharma, Inc. and NextCure, Inc. are both Biotechnology companies. IGC Pharma, Inc. and NextCure, Inc. are of similar size ($23.4M and $22.0M). NextCure, Inc. has the higher net margin (0.00% vs −836.1%) and the higher return on invested capital (0.00% vs −90.5%). Across the 16 metrics below, NextCure, Inc. leads on 9 and IGC Pharma, Inc. on 7.

Valuation

Metric IGC NXTC Biotechnology median
P/E n/m n/m 10.60
P/S 18.89 1.03 9.40
P/B 3.20 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 19.31 0.39 9.02
Earnings yield (47.37%) (193.55%) (32.88%)
Free cash flow yield (27.39%) (133.11%) (23.13%)

Profitability

Metric IGC NXTC Biotechnology median
Gross margin 23.89% 0.00% 68.51%
Operating margin (914.80%) 0.00% 0.00%
Net margin (836.06%) 0.00% 0.00%
Free cash flow margin (485.92%) 0.00% 0.00%
Return on equity (126.16%) (195.22%) (51.96%)
Return on assets (94.55%) (121.60%) (46.06%)
Return on invested capital (90.48%) 0.00% 0.00%

Growth

Metric IGC NXTC Biotechnology median
Revenue growth (TTM) (17.03%) — 6.76%
EPS growth (last fiscal year) 57.85% 17.75% 29.88%
Revenue growth, 5-year CAGR (20.77%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IGC NXTC Biotechnology median
Debt to equity 0.13 0.00 0.00
Current ratio 0.42 3.47 4.97
Net debt to EBITDA 0.04 0.75 1.01

Dividend

Metric IGC NXTC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IGC NXTC Biotechnology median
Market cap 21.95m 23.44m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack